- Date: February 14, 2019
Judit Cubedo (centre) with GlyCardial Diagnostics team members, Javier Sábado and Lola Fernández.
The 2015 CaixaImpulse selected project Apo J-Glyc, now GlyCardial Diagnostics, has recently received €1.9 million in the SME instrument phase II funding of the Horizon 2020 programme, an initiative of the European Commission. This brings public funding and soft loans raised by the company in the past year to a total of €2.4 million, with grants also obtained from the EIT Health Headstart programme and the Retos-Colaboración project from the Ministerio de Ciencia, Innovación y Universidades.
For Judit Cubedo, the company’s co-founder and CEO, the funding represents an important step in the advancement of the project, which is a spin-off from the Sant Pau Research Institute. “It is amazing and highly motivating to see that the EU trusts in our project as much as we do”, she commented.
GlyCardial Diagnostics is developing a kit for the early diagnosis of cardiac ischemia. The funds they have received will be used to carry out the clinical validation of the novel in vitro test for the early detection of cardiac ischemia, as well as to advance in the development of a fast-test for the rapid detection of its biomarker in blood samples.
“We are about to start the clinical study for the validation of the biomarker. This will be a prospective international study where we will be able to analyse the performance of our novel test in the real clinical setting”, said Judit. “We are very thankful to all our collaborators that have made the project a success.”
More programme highlights
May 02, 2019
A visual representation of our diverse community, made up of men and women from scientific, industrial and pharmaceutical backgrounds.
April 23, 2019
Josep Maria Font is the co-founder of ABLE Human Motion, a former CaixaImpulse project. We spoke to him to find out about the company’s progress and how this innovation will improve patients’ quality of life.
April 11, 2019
We spoke to two CaixaImpulse 2018 project leaders, who shared their experiences and tips for the next cohort.